ALKEMPharmaceuticals
Alkem Laboratories Ltd — PE Ratio & Valuation Analysis
₹5299.00
-1.40%
Current P/E28.54xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E38.2x25.3% below avg
✅
10.2% Discount to Industry
ALKEM P/E 28.54x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹181.11 | ₹5507 | 30.4x |
| 2024 | ₹150.19 | ₹5634 | 37.5x |
| 2023 | ₹82.31 | ₹5203 | 63.2x |
| 2022 | ₹137.63 | ₹3005 | 21.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Alkem Laboratories Ltd Valuation
Alkem Laboratories Ltd (ALKEM) currently trades at 28.54x earnings. The Pharmaceuticals sector average PE is 31.77x. ALKEM is trading at a discount to peers — may indicate relative value. Historically, ALKEM has traded at an average PE of 38.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
19.39%
Dividend Yield
0.80%
More on Alkem Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.